Zobrazeno 1 - 10
of 395
pro vyhledávání: '"Kuo-How Huang"'
Autor:
Chu-Wen Fang, Hui-Lung Hsieh, Shuo-Meng Wang, Kuo-How Huang, Kang-Yung Peng, Yen-Hung Lin, Vin-Cent Wu, Jeff S. Chueh
Publikováno v:
BMC Nephrology, Vol 25, Iss 1, Pp 1-12 (2024)
Abstract Background Primary aldosteronism (PA), which is present in 5–18% of hypertensive patients, is a leading cause of secondary hypertension. Adrenalectomy is often recommended for patients with unilateral primary aldosteronism (uPA), yielding
Externí odkaz:
https://doaj.org/article/d5b86ea7c9c349c098f7c959c6a641fd
Autor:
Jian-Hua Hong, Ming-Chieh Kuo, Yung-Ting Cheng, Yu-Chuan Lu, Chao-Yuan Huang, Shih-Ping Liu, Po-Ming Chow, Kuo-How Huang, Shih-Chieh Jeff Chueh, Chung-Hsin Chen, Yeong-Shiau Pu
Publikováno v:
The World Journal of Men's Health, Vol 42, Iss 3, Pp 587-599 (2024)
Purpose: Active surveillance (AS) is one of the management options for patients with low-risk and select intermediate-risk prostate cancer (PC). However, factors predicting disease reclassification and conversion to active treatment from a large po
Externí odkaz:
https://doaj.org/article/41d3fd7dae4a4e9e950de04720ad2b31
Autor:
Chu-Wen Fang, Chi-Shin Tseng, Kang-Yung Peng, Vin-Cent Wu, Shuo-Meng Wang, Kuo-How Huang, Jeff Shih-Chieh Chueh
Publikováno v:
Urological Science, Vol 35, Iss 1, Pp 3-8 (2024)
Primary aldosteronism (PA), the most important cause of secondary endocrine hypertension, is hallmarked by excessive aldosterone secretion. There were 2 subtypes of PA—unilateral aldosterone-producing adenoma and bilateral adrenal hyperplasia, whic
Externí odkaz:
https://doaj.org/article/9dbbf8a4f43d494f8ddcab1d613c23d0
Autor:
Yu-Jen Wang, Chi-Shin Tseng, Chao-Yuan Huang, Chung-Hsin Chen, So-Meng Wang, Kuo-How Huang, Po-Ming Chow, Yeong-Shiau Pu, Jeff Shih-Chieh Chueh, Shiu-Dong Chung, Jason Chia-Hsien Cheng
Publikováno v:
Biomedicines, Vol 12, Iss 10, p 2275 (2024)
Background/Objectives: Patients with non-metastatic castration-resistant prostate cancer (nmCRPC) and high-risk features frequently have progression to life-threatening metastasis without second-generation antiandrogens. This study investigated nmCRP
Externí odkaz:
https://doaj.org/article/94ea2809b1244126ad4de5238862fcd1
Autor:
Chi-Shin Tseng, Chieh-Kai Chan, Hsiang-Ying Lee, Chien-Ting Pan, Kang-Yung Peng, Shuo-Meng Wang, Kuo-How Huang, Yao-Chou Tsai, Vin-Cent Wu, Jeff S. Chueh
Publikováno v:
Journal of the Formosan Medical Association, Vol 123, Iss , Pp S125-S134 (2024)
Primary aldosteronism (PA) is the most common cause of secondary hypertension and one of the few medical diseases that can be cured by surgery. Excessive aldosterone secretion is highly associated with cardiovascular complications. Many studies have
Externí odkaz:
https://doaj.org/article/d2dfe1d945c4446083af2362b46a812c
Autor:
Yu-Cheng Lu, Kao-Lang Liu, Vin-Cent Wu, Shuo-Meng Wang, Yen-Hung Lin, Shih-Chieh Jeff Chueh, Kwan-Dun Wu, Yann-Rong Su, Kuo-How Huang
Publikováno v:
Journal of the Formosan Medical Association, Vol 122, Iss 5, Pp 393-399 (2023)
Purpose: Mineralocorticoid receptor antagonists are the first-line treatment for bilateral adrenal hyperplasia (BAH) with primary aldosteronism (PA), while unilateral adrenalectomy is the standard treatment for aldosterone-producing adenoma (APA). In
Externí odkaz:
https://doaj.org/article/1a0361bbd9064167a64ed63149459e70
Autor:
Ting-Wei Kao, Che-Wei Liao, Cheng-Hsuan Tsai, Yi-Yao Chang, Chien-Ting Pan, Chin-Chen Chang, Bo-Ching Lee, Wei-Chieh Huang, Kuo-How Huang, Ching-Chu Lu, Tai-Shuan Lai, Chieh-Kai Chan, Jeff S. Chueh, Vin-Cent Wu, Chi-Sheng Hung, Zheng-Wei Chen, Yen-Hung Lin
Publikováno v:
Therapeutic Advances in Chronic Disease, Vol 14 (2023)
Background: Primary aldosteronism (PA) has been associated with atherosclerosis beyond the extent of essential hypertension, but the impact of albuminuria remains unknown. Objective: To investigate the effect of concomitant albuminuria on arterial st
Externí odkaz:
https://doaj.org/article/3134d6bc5c564d709c334aed2fd1b4c7
Autor:
Po-Ming Chow, Jun-Ren Dong, Yu-Wei Chang, Kuan-Lin Kuo, Wei-Chou Lin, Shing-Hwa Liu, Kuo-How Huang
Publikováno v:
Molecular Therapy: Oncolytics, Vol 26, Iss , Pp 387-398 (2022)
Urothelial carcinoma (UC) comprises the majority of bladder cancers. Standard platinum-based chemotherapy has a response rate of approximately 50%, but drug resistance develops after short-term treatment. Deubiquitinating (DUB) enzyme inhibitors incr
Externí odkaz:
https://doaj.org/article/b731b11f8e4446e89c0070c4129fb7f0
Autor:
Yu-Cheng Lu, Chao-Yuan Huang, Chia-Hsien Cheng, Kuo-How Huang, Yu-Chuan Lu, Po-Ming Chow, Yi-Kai Chang, Yeong-Shiau Pu, Chung-Hsin Chen, Shao-Lun Lu, Keng-Hsueh Lan, Fu-Shan Jaw, Pei-Ling Chen, Jian-Hua Hong
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-10 (2022)
Abstract To compare clinical outcomes between the use of robotic-assisted laparoscopic radical prostatectomy (RP) and radiotherapy (RT) with long-term androgen deprivation therapy (ADT) in locally advanced prostate cancer (PC), 315 patients with loca
Externí odkaz:
https://doaj.org/article/161e7d8ad5d745e4bf7f60120f2917ff
Outcomes of stratified transurethral resection of bladder tumor: A propensity score-matched analysis
Autor:
Wei-Lun Huang, Chao-Yuan Huang, Kuo-How Huang, Yeong-Shiau Pu, Hong-Chiang Chang, Po-Ming Chow
Publikováno v:
Journal of the Formosan Medical Association, Vol 121, Iss 1, Pp 73-80 (2022)
Background/purpose: Several strategies have been reported for improving the integrity of transurethral resection of bladder tumor (TURBT). However, no standard has been established. Stratified TURBT (SR) is one of protocols for TURBT, wherein exophyt
Externí odkaz:
https://doaj.org/article/17fa50a4bcef4b53a2ef5a2dd17357af